Our Offer for Emerging Pharmaceutical Companies

Eurofins CDMO is designed for small & innovative pharmaceutical companies, from early stages!

70% of our clients portfolio are small size & start-up companies
50% of our projects are linked to pre-clinical and phase I studies

Why should you select us:

✔ Overview of the whole preclinical & clinical project (budget and timelines)
✔ The right set of API/DP (Drug Product) services provided in function of the stage of your project since phase I
✔ High flexibility in terms of workload management and high reactivity, to adapt to changes in your drug development journey
✔ Dedicated project management team
✔ Innovative development technologies
✔ Ensure regulatory compliance throughout each stage of the development cycle
✔ 100% dedicated to your projects (No IPs on technologies or developments)

Our sales and project management team is at your disposal to help you in your drug development projects.